Skip to main content
Pakistan Journal of Medical Sciences logoLink to Pakistan Journal of Medical Sciences
. 2019 Mar-Apr;35(2):477–482. doi: 10.12669/pjms.35.2.603

The outcomes of transobturator tape intervention in the treatment of stress urinary incontinence: Two years’ follow-up

Bulat Aytek Sik 1, Hanife Copur 2, Yilda Arzu ABA 3,
PMCID: PMC6500847  PMID: 31086536

Abstract

Objective:

To evaluate the clinical outcomes and the effects on quality of life of transobturator tape surgery during a 2-year follow-up period in our clinics.

Methods:

Eighty-seven patients with stress or mixed urinary incontinence who underwent transobturator tape surgery were included in the study conducted in Istanbul. Taksim. Training. and Research Hospital Gynecology and Obstetrics Clinic, between 2011 and 2013. The patients’ demographic features, incontinence questionnaires, quality of life scores [Incontinence Impact Questionnaire (IIQ-7) and urinary distress inventories (UDI-6)], examination findings, urodynamic results, stress tests, Q tip tests, number of daily pads, ultrasonography, surgery, and cystoscopy results were recorded. Patients were evaluated 23-27 months (mean: 25.40±1.31 months) after their discharge in terms of symptoms, quality of life scores, urodynamic findings, complications, and stress test.

Results:

Sixty-three (72.4%) patients had stress incontinence and 24 (27.6%) patients had mixed urinary incontinence. No perioperative complications were observed in our study. After a follow-up period of two years, a significant improvement was detected in the IIQ-7 and UDI-6 questionnaires when compared with the preoperative period. Moreover, the objective cure rate was found as 88.5% (n=77). De novo urge incontinence was obtained in 5.7% (n=5) of patients and was treated with anticholinergics. Perineal pain was present in 3 (3.44%) patients and was treated with analgesics and cold packs. In 2 (2.29%) patients, vaginal mesh erosion was detected and full recovery was achieved with an excision. Urinary retention and bladder perforation was not seen in any patients.

Conclusion:

Our study revealed a high objective cure rate, and an improvement in symptoms and quality of life with the transobturator tape operation.

Keywords: Mixed urinary incontinence, Outcomes, Stress urinary incontinence, Transobturator tape

INTRODUCTION

As one of the most common problems faced in the gynecology/obstetrics practice, stress urinary incontinence (SUI) affects about 4-35% of all women. The successful treatment of this problem, which negatively affects women’s quality of life, is highly important for the patient. Patients usually become self-conscious about sharing this problem with physicians and procrastinate about consulting a physician on the subject. Although conservative methods such as vaginal pessaries and pelvic floor exercises are available, success rates are low. In cases where these methods fail, various surgical treatments are available for treatment.1 Presented for the first time in the literature in 2001 as a minimally invasive technique, transobturator tape (TOT) surgery comprises the placement of a sling material under the urethra with a transobturator approach.2,3 This sling material imitates the role of the pubo-urethral ligament located in this area, whose weakening causes incontinence, and provides sling-like support under the urethra. Heinonen et al. reported the objective and subjective cure rates with a follow-up period of 6.5 years of TOT treatment in SUI as 89% and 83%, respectively.4 In the literature, similar rates have been reported in various studies that evaluated the success of TOT treatment in SUI over different follow-up periods.5,6

We performed the inside-out TOT technique to a patient group with symptoms of stress or mixed urinary incontinence (MUI) and we aimed to present the success rates, and short and long-term complications of our clinic.

METHODS

This prospective study was conducted by one physician in Istanbul Taksim Training and Research Hospital Gynecology and Obstetrics Clinic, between 2011 and 2013, with 87 patients who had symptoms of urinary incontinence and were diagnosed as having SUI/MUI. This study was approved by the local ethics committee of Istanbul Taksim Training and Research Hospital and written informed consent was obtained from each participant. Patients aged between 37 and 56 years who had SUI and underwent transobturator tape surgery were included in the study. Patients who had undergone surgery previously due to incontinence or pelvic organ prolapsus, those who wished to have children, those with additional gynecopathologies, patients in need of vaginal hysterectomies, and patients with MUI with urge incontinence symptoms were excluded from the study. Baseline assessments included demographic data, medical history, 1-h pad test, and multichannel urodynamic study (UD-2000, Medical Measurement System, Enschede, Netherlands). The quality of life of the patients was evaluated via questionnaires, which included the short form of the Urinary Distress Inventory (UDI-6), and Incontinence Impact Questionnaire (IIQ-7).7 Patients were pre- and post-operatively evaluated. SUI diagnosis was evaluated subjectively with a stress test and bladder neck mobility was evaluated with a Q tip test. Urodynamic evaluation was performed with Laborie® Dorado urodynamics equipment. Pre- and postoperative cystometry tests were performed. Urine analysis and urine cultures were requested prior to urodynamic testing and in case of infection, urodynamic evaluation was postponed until after treatment. Cystometric evaluation was performed after measurement of residual urine. The bladder was filled with saline at room temperature at a rate of 50 mL/min. Patients were asked to cough after every 100 mL and urine leakage during or after coughing was detected. Detrusor contractions and related leakages were recorded. The first and severe urine sensations of patients were recorded. Abdominal leak point pressures (ALPL) were used to determine the subtypes of SUI. Low ALPL (0-60 cm H2O) was used as a criterion for Type 3 SUI. For Type 2 SUI, ALPL had to be higher (90 cm H2O). Detrusor instability was determined by the detection of an increase of 15 cm H2O or higher in detrusor pressure. For prophylactic reasons, one g cefazolin was administered prior to surgery and two g of cefazolin was administered after surgery. All patients underwent surgery with spinal anesthesia. In the surgery, TVT-Obturator inside-out (Ethicon®, USA) equipment was used. Cystoscopies were performed after the procedure to check the bladder and urethra. In patients who required it, additional procedures were performed after the placement of the Prolene band and the patient was asked to cough in order to adjust the tension of the band. The durations of TOT, cystoscopies, and additional procedures were recorded. The catheters were removed 24 hours after the surgery and patients with urine residues less than 100 mL were discharged. Intraoperative and postoperative complications were recorded.

Data analyses were performed using the Statistical Package for Social Science (SPSS Inc, Chicago, Illonois, USA) 10.0 program. Continuous data are expressed as mean ± standard deviation (SD) and statistical significance was evaluated using the Wilcoxon signed-rank test. Categorical data are reported as numerical values and percentages. A p value <0.05 was considered as statistically significant.

RESULTS

In our study, the mean age of the patients was 46.55 ± 5.74 years (min 37, max 56 years). The mean parity of our patients was 4.05 ± 2.09 (min 2, max 11). According to the obstetric history, 82 (94.2%) patients had vaginal births and four patients had cesarean sections. A total of 26 (29.8%) patients were in menopause. The mean body mass index of the patients was 30.9±4.57 kg/m2. A total of 63 (72.4%) patients were diagnosed as having SUI and 24 (27.6%) patients had MUI in the urodynamic evaluation. In the physical examination, rectocele was detected in 24 patients, cystocele was detected in 72 patients, and ureterocele was detected in 16 patients (Table-I).

Table-I.

The demographical properties of patients who received TOT.

Demographical properties of patients X ± ss
 Age 46.55±5.74
 Parity 4.05±2.09
 Gravida 5.07±3.09
 Body Mass Index 30.9±4.57

n (%)

 Vaginal birth 76 (94.2)
 Sectio 4 (5.8)
 Menopause 26 (29.8)
 Rectoceles 24 (27.6)
 Cystoceles 72 (82.8)
 Ureteroceles 16 (18.4)
 Hysterectomies 12 (13.8)

Colporrhaphy anterior (CA) was additionally performed on 28 (32%) patients and colporrhaphy posterior (CP) was additionally performed on 4 (4.5%) patients during the operation. TOT procedures alone were performed on 59 (67.8%) patients. After subtracting cystoscopy and additional procedure durations, the mean duration of operation was 10.3 ± 2.74 minutes (min. 6, max. 15 minutes). No intraoperative complications (e.g., hemorrhage, injury to the bladder, urethra or nerves, vascular injury, hematoma) occurred. The mean residual urine volume at the 24th hour following surgery was 41.5 ± 121.9 mL (min. 0, max. 550 mL). With the exception of four patients who had a residual urine volume of 550 mL, all patients were discharged in the 1st postoperative day; the mean duration of stay at the hospital was 1.2 ± 0.89 days. The mean follow-up period of the patients was 25.4 ± 1.31 months (min. 23, max. 27 months).

The mean number of micturition’s during the day and night before the surgery was 6.30 ± 2.83 (min. 3, max. 12) and 1.5 ± 1.40 (min. 0, max. 4), respectively. The mean number of daily pads was 1.5 ± 1.40 (min. 0-max. 4). The mean Q tip test finding was 41.5 5 ± 22.6 (min. 15, max. 80) (Table II).

Table-II.

Preoperative and postoperative characteristics of the patients.

Preoperative and postoperative characteristics of the patients Preoperative X ± ss Postoperative (2nd year) X ± ss P
Number of micturitions during the day 6.30 ± 2.83 4.34±1.88 0.001**
Number of nocturnal urinations 1.40±1.20 1.20±0.56 0.1615
First urinary sensation 178.5±89.05 159.0±39.16 0.0640
Maximum capacity 529.5±80.6 518.75±51.6 0.2968
Residual urinary volume 13.50±3.66 14.09±4.08 0.663
Maximum detrusor pressure 11.60±2.80 10.95±2.95 0.6500
Bladder compliance measurements 63.76±30.79 59.40±11.27 0.2175
IIQ-7 Scores 11.00±2.03 1.25±2.09 0.001**
UDI-6 Scores 9.55±3.03 3.15±1.78 0.001**
Number of Daily pads 3.55±1.43 0.40±0.60 0.001**
Q tip test 41.5 5 ± 22.6 37.75±12.70 0.3078

Despite the postoperative decrease in the number of micturitions during the day and night, the values during the day were statistically significant (p=0.001). According to Q tip test results, bladder neck mobility did not change after surgery (p=0.307). SUI was urodynamically detected in 8 (9.1%) patients and de novo UI was detected in 4 (4.5%) patients after long-term follow-up. The amount of residual urinary volumes during postoperative follow-ups did not change when compared with the preoperative period (p=0.663). No significant change was observed in the first urinary sensation, bladder capacity, bladder compliance or maximum detrusor pressure during the follow-up period. The preoperative and postoperative characteristics of the patients are presented in Table-II.

A significant improvement was seen in the IIQ-7 and UDI-6 questionnaires, which were performed to evaluate the patients’ quality of life when compared with the pre-operative period. In our study, the objective recovery rate of our patients was found as 88.5% (n=77) in their two- year follow-up. De novo urge incontinence was seen in 5.7% (n=5) of patients and was treated with anticholinergics. Urinary retention and bladder perforation was not seen in any patients. Perineal pain was seen in 3 (3.44%) patients and was treated with analgesics and cold packs. In two (2.29%) patients, vaginal mesh erosion was seen and full recovery was achieved with an excision. The TOT surgical success and complication rates are shown in Table-III.

Table-III.

Success and surgical complication rates of transobturator tape surgery.

Operative results and complications n (%)
Full recovery after surgery 77 (88.5)
Urinary retention 0
Perineal pain 3 (3.44)
De novo urge incontinence 5 (5.7)
Mesh erosion 2 (2.29)
Bladder injury 0

DISCUSSION

Despite the variety of surgical interventions proposed for SUI, tension-free vaginal tape (TVT) continues to be one of the most frequently practiced interventions.8 TVT is seen to be as effective as Burch’s colposuspension in two-year follow-up.9 Despite its relative safety, potential and major complications such as bladder perforation, and urethral and intestinal injuries have been reported related to the Retzius space. The main concerns regarding these techniques are related to potential vaginal or urethral mesh erosion risks. This is why TOT, which does not decrease the effectiveness in the short term, was designed as an alternative to mesh tapes.10 In the transobturator technique defined by Delorme, the tape is passed between the obturator foramina outside-in (tensely towards under the urethra).3 Many series have reported similar success rates for the TOT procedure in the treatment of SUI.9-12,14,16 In a series in which 117 patients were followed up for three months, DeTayrac reported the one-year recovery rate of TOT as 84% (10). The stress test and urodynamic evaluation performed at the 2nd year in our study showed that TOT had a success rate of 90%. Four (5%) patients who had symptoms of urgency during the follow-up period had de novo urge incontinence. Based on our 2-year experience, it can be said that the TOT demonstrates similar results to the gold standard Burch colposuspension or TVT with its 90% recovery rate. 10,13,14 After a study by Domingo et al. in 2005, the TOT success rate was found as 96.8%.11 Grise et al. reported the success rate of the procedure as 80% in their study, which involved following up 206 patients for one year. In addition, they demonstrated that 56.6% and 53.8% of the patients’ immediate urge to urinate with or without urge incontinence disappeared, respectively.15 Although rate of newly occurring urge incontinence was 5% and statistically significant in our study, it might also reflect TOT’s minor obstructive effects.

Preoperative and emergency post-operative TOT complications are rare. In the study of Mellier et al., one patient had urethral perforation.14 Costa et al. suggested that if the lesion was not superficial, it was safer to delay the implantation.13 Bleeding was reported in 0.8% of the patients, which was treated only with compression.16,17 The perforated lateral urethral space under the pelvic fascia is not crossed by veins. Also, Spinose et al. recently showed that the outside-in pathway was distant from the posterior branch of the obturator nerve and inferior external pudendal artery.16 The risk of bladder perforation decreases dramatically with the TOT technique. Krauth et al. calculated this rate to be approximately 0.5%.17 No perforation was seen in the routine cystoscopies of 38 patients.18 Accordingly, cystoscopy is recommended in cases of previous or simultaneous prolapsus. In our study, a routine cytoscopic procedure was performed on each patient following the surgery and no cases of perforation were seen.

De novo urge incontinence, which is rarely seen after TOT operations, indicates that the obstructive effect of the surgery is minimal. In our study, the rate of de novo urges negatively affecting the quality of life was found as low (5.7%) (n=5), consistent with the literature.19,20 Perineal pain, which was reported at a rate of 2.3-5% after TOT surgery in the literature, was seen at a rate of 3.44% (n=3) in our study, and disappeared within the first month. The results of our study are consistent with the literature.21,22 Vaginal mesh erosion was seen in the early period in 2.29% (n=2) of the patients. Our rate is low compared with the review and meta-analysis results by Latthe et al.23 Our short follow-up period might account for the low rates of erosion because vaginal erosion is usually one of the long-term complications of TOT surgery.

One of the longest follow-up periods in the literature is in the study by Alcalay et al.24 In their study, patients were followed up for 10-20 years and it was determined that the success rate diminished with time and reached a plateau at the end of 10-12 years. Again, in the same study, the success rate was reported as 69%. The newly practiced incontinence surgeries have been compared with this procedure because the long-term results of retropubic colposuspension surgeries are much better known. The success rate of open retropubic colposuspension surgeries has been determined as being between 68.9% and 88%.

Our TOT results emerged as similar to open retropubic colposuspension surgeries.25,26 However, being less invasive and having fewer adverse effects has made TOT surgery more popular in recent years. Kim et al. compared TOT results at the first and 3rd year and stated that although the success rate was 70% in the first year, it decreased to 60% in the third year. Only our long-term results are given in the present study, which suggests that the first-year results could have been found much higher.27

CONCLUSIONS

Our two-year follow-up results showed that TOT was an effective technique with a low risk of complications. These results support the evidence that the TOT procedure should be considered a better and more beneficial option as compared with TVT.

Acknowledgements

None.

Footnotes

Conflict of Interest: The authors declare that they have no conflict of interests.

Grant Support & Financial Disclosures: None.

Authors Contribution

BAS, HC, YAA conceived, designed and did statistical analysis & editing of manuscript.

BAS & HC: did data collection and manuscript writing.

BAS & YAA: did review and final approval of manuscript.

REFERENCES

  • 1.Wall LL. Urinary stress incontinence. In: Rock JA, Mjones HW, editors. Telinde's Operative Gynecology. Vol. 87. Philadelphia: Lippincott Williams &Wilkins Company; 2003. pp. 257–265. [Google Scholar]
  • 2.Delancey Wei JT, De Lancey JO. Functional anatomy of the pelvic floor and lower urinary tract. Clin Obstet Gynecol. 2004;47:3–17. doi: 10.1097/00003081-200403000-00004. [DOI] [PubMed] [Google Scholar]
  • 3.Delorme E. Transobturator urethral suspension:mini-invasive procedure in the treatment of stress urinary incontinence in women. Prog Urol. 2001;11:1306. [PubMed] [Google Scholar]
  • 4.Heinonen P, Ala-Nissila S, Raty R, Laurikainen E, Kiilholma P. Objective cure rates and patient satisfaction after the transobturator tape procedure during 6.5-year follow-up. J Minim Invasive Gynecol. 2013;20(1):73–78. doi: 10.1016/j.jmig.2012.09.007. doi:10.1016/j.jmig.2012.09.007. [DOI] [PubMed] [Google Scholar]
  • 5.Liapis A, Bakas P, Creatsas G. Efficacy of inside-out transobturator vaginal tape (TVTO) at 4 years follow up. Eur J Obstet Gynecol Reprod Biol. 2010;148(2):199–201. doi: 10.1016/j.ejogrb.2009.11.004. doi:10.1016/j.ejogrb.2009.11.004. [DOI] [PubMed] [Google Scholar]
  • 6.Waltregny D, Gaspar Y, Reul O, Hamida W, Bonnet P, de Leval J. TVT-O for the treatment of female stress urinary incontinence:results of a prospective study after a 3-year minimum follow-up. Eur Urol. 2008;53:401–8. doi: 10.1016/j.eururo.2007.08.021. doi:10.1016/j.eururo.2007.08.021. [DOI] [PubMed] [Google Scholar]
  • 7.Uebersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl JA. Short forms to assess life quality and symptom distress for urinary incontinence in women:the incontinence Impact questionnaire and the urogenital distress inventory. Continence program for women Research group. Neurourol Urodyn. 1995;14:131–9. doi: 10.1002/nau.1930140206. [DOI] [PubMed] [Google Scholar]
  • 8.Kuuava N, Nilsson CG. A nationwide analysis of complications associated with the tension-free vaginal tape (TVT) procedure. Acta Obstet Gynecol Scand. 2002;81:72–77. doi: 10.1034/j.1600-0412.2002.810113.x. doi:10.1034/j.1600-0412.2002.810113.x. [DOI] [PubMed] [Google Scholar]
  • 9.Ward KL, Hilton P UK and Ireland TVT Trial Group. A prospective multicenter randomized trial of tension-free vaginal tape and colposuspension for primary urodynamic stres incontinence:two-year follow-up. Am J Obstet Gynecol. 2004;190:324–331. doi: 10.1016/j.ajog.2003.07.029. doi:10.1016/j.ajog.2003.07.029. [DOI] [PubMed] [Google Scholar]
  • 10.De Tayrac R, Deffieux X, Droupy S, Chauveaud-Lambling A, Calvanese-Benamour L, Fernandez H. A prospective randomized trial comparing tension- free vaginal tape and transobturator suburetral tap efor surgical treatment of stres urinary incontinence. Am J Obstet Gynecol. 2004;190:602–608. doi: 10.1016/j.ajog.2003.09.070. doi:10.1016/j.ajog.2003.09.070. [DOI] [PubMed] [Google Scholar]
  • 11.Domingo S, Alama P, Ruiz N, Perales A, Pellicer A. Diagnosis, management and prognosis of vaginal erosion after transobturator suburetral tape procedure using a non-woven thermally bonded polypropylen mesh. J Urol. 2005;173:1627–1630. doi: 10.1097/01.ju.0000154941.24547.0f. doi:10.1097/01.ju.0000154941.24547.0f. [DOI] [PubMed] [Google Scholar]
  • 12.Delorme E, Droupy S, de Tayrac R, Delmas V. Transobturator tape (Urotape®):a new minimally-invasive procedure to treat female urinarfy incontinence. Eur. Urol. 2004;45:203–207. doi: 10.1016/j.eururo.2003.12.001. doi:10.1016/j.eururo.2003.12.001. [DOI] [PubMed] [Google Scholar]
  • 13.Costa P, Grise P, Droupy S, Monneins DF, Assenmacher C, Ballanger P, et al. Surgical treatment of female stres urinary incontinence with a trans-obturator-tape (T.O.T) Urotape:short term results of a prospective multicentric study. Eur Urol. 2004;46:102–106. doi: 10.1016/j.eururo.2004.03.005. doi:10.1016/j.eururo.2004.03.005. [DOI] [PubMed] [Google Scholar]
  • 14.Mellier G, Benayed B, Bretones S, Pasquier JC. Suburetral tape via the obturator route:is the TOT a simplification of the TVT? Int Urogynecol J Pelvic Flor Dysfunct. 2004;15:227–232. doi: 10.1007/s00192-004-1162-8. [DOI] [PubMed] [Google Scholar]
  • 15.Grise P, Droupy S, Saussine C, Ballanger P, Monneins F, Hermieu JF, et al. Transobturator tape sling for female stress incontinence with polypropylene tape and outside-in procedure:prospective study with 1 year of minimal follow-up and review of transobturator tape sling. Urology. 2006;68(4):759–763. doi: 10.1016/j.urology.2006.04.020. doi:10.1016/j.urology.2006.04.020. [DOI] [PubMed] [Google Scholar]
  • 16.Spinosa JP, Dubuis PY. Suburetral sling inserted by the transobturator rout in the treatment of female stres urinary incontinence:preliminary results in 117 cases. Eur J Obstet Gynecol Reprod. 2005;123:212–217. doi: 10.1016/j.ejogrb.2005.04.016. doi:10.1016/j.ejogrb.2005.04.016. [DOI] [PubMed] [Google Scholar]
  • 17.Krauth JS, Rasoamiaramanana H, Bartela H. Suburetral tape treatment of female urinary incontinence-morbidity assessment of the transobturator route and a new tape (I-STOP):a multicentre experiment involving 602 cases. Eur Urol. 2005;47:102–107. doi: 10.1016/j.eururo.2004.08.015. doi:10.1016/j.eururo.2004.08.015. [DOI] [PubMed] [Google Scholar]
  • 18.Dargent D, Bretones S, George P. Insertion of a suburetral sling through the obturating membrane for treatment of female urinary incontinence. Gynecol Obstet Fertil. 2002;30:576–582. doi: 10.1016/s1297-9589(02)00389-2. doi:10.1016/S1297-9589(02)00389-2. [DOI] [PubMed] [Google Scholar]
  • 19.Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women:Results from the EPIC study. BJU Int. 2008;101:1388–1395. doi: 10.1111/j.1464-410X.2008.07601.x. doi:10.1111/j.1464-410X.2008.07601.x. [DOI] [PubMed] [Google Scholar]
  • 20.Juma S, Brito CG. Transobturator tape (TOT):Two years'follow-up. Neurourol Urodyn. 2007;26:37–41. doi: 10.1002/nau.20353. doi:10.1002/nau.20353. [DOI] [PubMed] [Google Scholar]
  • 21.Krauth JS, Rasoamiaramanana H, Barletta H, Barrier PY, Grisard-Anaf M, Lienhart J, et al. Sub-urethral tape treatment of female urinary incontinence;morbidity assessment of the transobturator route and a new tape (I-STOP):A multicentre experiment involving 604 cases. Eur Urol. 2005;47:102–106. doi: 10.1016/j.eururo.2004.08.015. doi:10.1016/j.eururo.2004.08.015. [DOI] [PubMed] [Google Scholar]
  • 22.Meschia M, Bertozzi R, Pifarotti P, Baccichet R, Bernasconi F, Guercio E, et al. Perioperative morbidity and early results of a randomised trial comparing TVT and TVT-O. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18:1257–1261. doi: 10.1007/s00192-007-0334-8. [DOI] [PubMed] [Google Scholar]
  • 23.Latthe PM, Foon R, Toozs-Hobson P. Transobturator and retropubic tape procedures in stress urinary incontinence:a systematic review and meta-analysis of effectiveness and complications. BJOG. 2007;114:522–531. doi: 10.1111/j.1471-0528.2007.01268.x. doi:10.1111/j.1471-0528.2007.01268.x. [DOI] [PubMed] [Google Scholar]
  • 24.Alcalay M, Monga A, Stanton SL. Burch colposuspension:A 10-20 year follow up. Br J Obstet Gynaecol. 1995;102:740–745. doi: 10.1111/j.1471-0528.1995.tb11434.x. doi:10.1111/j.1471-0528.1995.tb11434.x. [DOI] [PubMed] [Google Scholar]
  • 25.Mayekar RV, Bhosale AA, Kandhari KV, Nandanwar YS, Shaikh SS. A study of transobturator tape in stress urinary incontinence. Urol Ann. 2017;9(1):9–12. doi: 10.4103/0974-7796.198867. doi:10.4103/0974-7796.198867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Karmakar D, Mostafa A, Abdel-Fattah M. Long-term outcomes of transobturator tapes in women with stress urinary incontinence:E-TOT randomised controlled trial. BJOG. 2017;124(6):973–981. doi: 10.1111/1471-0528.14561. doi:10.1111/1471-0528. [DOI] [PubMed] [Google Scholar]
  • 27.Kim S, Son JH, Kim HS, Ko JS, Kim JC. Tape Shortening for Recurrent Stress Urinary Incontinence After Transobturator Tape Sling:3-Year Follow-up Results. Int Neurourol J. 2010;14(3):164–169. doi: 10.5213/inj.2010.14.3.164. doi:10.5213/inj.2010.14.3.164. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Pakistan Journal of Medical Sciences are provided here courtesy of Professional Medical Publications

RESOURCES